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Background: Snakebite is a significant public health issue in tropical countries. In Brazil, some of the most common
snake envenomations are from Bothrops. Bothrops bites trigger local and systemic effects including edema, pain,
erythema, cyanosis, infections, and necrosis. Vellozia flavicans is a plant from the Brazilian “cerrado” (savanna) that is
popularly used as an anti-inflammatory medicine. Since inflammation develops quickly after Bothrops bites, which
can lead to infection, the aim of the present study was to observe possible anti-snake venom and antimicrobial
activities of V. flavicans (Vf).
Methods: The chromatographic profile of the main constituents from the Vf leaf hydroalcoholic extract was
obtained by thin-layer chromatography (TLC). The anti-snake venom activity was measured by Vf’s ability to
neutralize the in vitro neuromuscular blockade caused by Bothrops jararacussu venom (Bjssu) in a mouse phrenic
nerve-diaphragm model (PND). After a 20 min incubation, preparations of PND were added to Tyrode’s solution
(control); Vf (0.2, 0.5, 1, and 2 mg/mL); 40 μg/mL Bjssu; pre-incubation for 30 min with Bjssu and 1 mg/mL Vf; and a
Bjssu pretreated preparation (for 10 min) followed by 1 mg/mL Vf. Myographic recording was performed, and the
contractile responses were recorded. The antimicrobial activity (minimum inhibitory concentration [MIC] and
minimum bactericidal concentration [MBC]) was obtained for Staphylococcus aureus, Pseudomonas aeruginosa,
Escherichia coli, and Enterococcus faecalis, using gentamicin and vancomycin as positive controls.
Results: TLC analysis yielded several compounds from Vf, such as flavonoids (quercetin) and phenolic acids
(chlorogenic acid). Bjssu completely blocked the contractile responses of PND preparations, while Vf preserved 97%
(±10%) of the contractile responses when incubated with Bjssu. In the PND pretreated with Bjssu, Vf was able to
inhibit the neuromuscular blockade progress. MIC and MBC of Vf ranged from 2.5 to 5.0 mg/mL for P. aeruginosa
and S. aureus strains, while no antimicrobial activity was observed for E. coli and E. faecalis.
Conclusions: The hydroalcoholic extract from Vf leaves was able to neutralize and decrease the in vitro
neuromuscular blockade caused by Bjssu. However, it did not show significant antimicrobial activity against the
tested bacteria.
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Envenomation from snake attacks is a significant public
health problem in rural areas of tropical and subtropical
countries. According to the World Health Organization,
there are at least 421,000 accidents involving snakes and
20,000 deaths worldwide from snakebite each year [1].
In Brazil, the genus Bothrops is a major group of snakes
that commonly cause envenomation. Snakebites from this
genus, which includes those of Bothrops jararacussu, are
characterized by local and systemic effects, such as inflam-
mation at the bite site, ecchymosis, bleeding, and skin in-
fection with abscess. Snakebites are usually associated
with inoculation of bacteria present in the snake’s mouth,
which can lead to necrosis, gangrene, and amputation [2].
There are few reports on the in vivo neurotoxicity in-
duced by B. jararacussu venom. Some reports detail un-
specified signs [3-5] or describe systemic effects including
blindness, blurred vision, difficulty in swallowing, and par-
alysis, which are reminiscent of the actions of Crotalus
venom [6]. However, the in vitro irreversible neuromuscu-
lar blockade induced by B. jararacussu venom, which was
first demonstrated by Rodrigues-Simioni et al. [7], has in-
spired other studies with other species of Bothrops.
Vellozia flavicans Mart. ex Schult. (Velloziaceae) is a na-
tive plant from the Brazilian “cerrado” (savanna) vegetation,
popularly known as “canela-de-ema”. It is an herbaceous-
shrub used as an anti-inflammatory and anti-rheumatic
in folk medicine [8]. The Velloziaceae family contains
about 270 species of tropical monocotyledonous plants,
many of which are found in the Brazilian tropical scrub
growing on rock outcrops [9]. Branco et al. [10] charac-
terized the chemical constituents of V. graminifolia,
which shares phytochemical groups already found in
other Vellozia plants, such as flavonoids [11,12], diter-
penoids [13-15], and triterpenoids [16,17]. Although
the phytochemical elucidation is relatively advanced for
this family, little is known about the pharmacological
properties of specific species.
Plants used as anti-inflammatory medicines could be
potentially effective for treating snakebites. This pharma-
cological relation has been confirmed by studies that
found both anti-inflammatory and anti-venom proper-
ties from some plant extracts and their compounds
[18,19]. Therefore, as V. flavicans is popularly used as
anti-inflammatory medicine, it could have also some
anti-venom activity. To test this hypothesis, a model
using B. jararacussu venom is better than other venoms,
such as Crotalus durissus terrificus, because the latter
does not induce significant inflammation in the tissues
around the snake bite [20]. B. jararacussu venom causes
inflammation at the bite site and induces an irreversible
neuromuscular blockade in vitro, but not in vivo [7].
The aim of the present study was to observe the ability
of a hydroalcoholic extract obtained from V. flavicansleaves to neutralize the in vitro neuromuscular blockade
caused by B. jararacussu venom in a mouse phrenic
nerve-diaphragm model. In addition, the antimicrobial ac-
tivity of the same extract was verified against Staphylococ-
cus aureus, Pseudomonas aeruginosa, Escherichia coli, and
Enterococcus faecalis strains, using gentamicin and vanco-
mycin as positive controls. Thin-layer chromatography
(TLC) was used to observe the main chemical constitu-
ents of the extract.
Methods
Plant material
The leaves of V. flavicans were collected at Porto Nacional,
Tocantins State, Brazil, in September 2011, at S10° 44' 08.3"
and W048° 21' 46.7". The plant was identified by the Botany
Section from Biology Department of Tocantins Federal
University, where a voucher specimen was deposited (HTO
8533). The V. flavicans leaves were dried at 37°C over 7 days
and then powdered, ground in a mill, and macerated over
5 days in 70% ethanol. Then, the suspension was perco-
lated (under protection against light) at 20 drops/min,
resulting in a 10% (w/v) hydroalcoholic extract [21]. The
extract was concentrated under reduced pressure, lyophi-
lized, and stored at room temperature without light and
humidity until the assays were performed.
Thin-layer chromatography
Aliquots of V. flavicans extract (10% w/v solved in ethanol
70% and sonicated for 20 min) were spotted (5 times) on
thin-layer silica gel plates (0.3 mm thick, Merck, Germany)
and compared with a collection of reference phytochemi-
cals [22]. The solvent system consisted of ethylacetate:
formic acid:acetic acid:water (100:11:11:24, w/v). Both
ethyl acetate and acetic acid were provided by Chemco
Ind. (Campinas, SP, Brazil), while formic acid was sup-
plied by Synth Chemical Co. (São Paulo, SP, Brazil).
The standard phytochemical groups were flavonoids
(quercetin and rutin) and phenolic acids (caffeic and
chlorogenic acids), suspended in 1% methanol (w/v, P.
A. solution, Sigma Chemical Co., St. Louis, MO, USA).
The separated spots were visualized (under UV light at
360 nm) with NP/PEG as follows: 5% (v/v) ethanolic NP
(diphenylboric acid 2-aminoethyl ester, Sigma Chemical
Co., St. Louis, MO, USA) followed by 5% (v/v) ethanolic
PEG 4000 (polyethylene glycol 4000, Synth Chemical Co.,
São Paulo, SP, Brazil). The retention factors (Rf) of the ex-
tract spots were compared with the Rf of standards.
Antiophidian activity
V. flavicans hydroalcoholic extract solubilization
The lyophilized extract was solubilized in 30 μL dimethyl
sulfoxide (DMSO; Sigma) and added to Tyrode’s solution
(5 mL) before addition to the bath containing the bio-
logical preparation (see below). This DMSO concentration
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muscular preparation [23].
Venom
Crude venoms were collected from male and female
adult B. jararacussu specimens (Bjssu, DL50mouse, e.v. =
5.18 mg/kg), in a glass receptacle covered with plastic
paraffin film to avoid saliva contamination. The snake
specimens are kept in the Serpentário do Centro de
Estudos da Natureza – CEN at the University of Vale do
Paraiba (UNIVAP, São José dos Campos, SP, Brazil) [24].
After collection, the venom was immediately placed in
an ice bath, lyophilized, and kept in a refrigerator at 4°C.
This process was certified by Professor Dr José Carlos
Cogo from UNIVAP.
Animals
Male Swiss white mice (26–32 g) were provided by Ani-
mais de Laboratorio (Anilab, Paulinia, Brazil) and housed
at 25 ± 3°C on a 12 h light/dark cycle, with food and water
ad libitum. This study was approved by the institutional
Commission for Ethics in the Use of Animals (CEUA) at
the Federal University of São Carlos (UFSCAR) under
protocol number 063/2012. All the experiments were per-
formed following the guidelines of the Brazilian Society of
Laboratory Animal Science (SBCAL).
Mouse phrenic nerve-diaphragm muscle (PND) preparation
The phrenic nerve-diaphragm [25] was obtained from
mice anesthetized with halothane and killed by exsan-
guination. The diaphragm was removed and mounted
under a tension of 5 g/cm in a 5 mL organ bath contain-
ing aerated Tyrode’s solution (control). This solution
was composed of the following constituents (in mM):
NaCl 137, KCl 2.7, CaCl2 1.8, MgCl2 0.49, NaH2PO4
0.42, NaHCO3 11.9, and glucose 11.1.
After stabilization with 95% O2 / 5% CO2 (v/v), the pH
of the solution was 7.0. Preparations were indirectly stim-
ulated with supramaximal stimuli (4× threshold, 0.06 Hz,
0.2 ms) delivered by bipolar electrodes from a stimulator
(model ESF-15D, Ribeirão Preto, SP, Brazil) to the nerve.
Isometric twitch tension was recorded with a force dis-
placement transducer (cat. 7003, Ugo Basile, Italy) coupled
to a 2-Channel Recorder Gemini physiograph device
(cat. 7070, Ugo Basile) via a Basic Preamplifier (cat.
7080, Ugo Basile). The PND myographic recording was
performed according to Ferraz et al. [26]. PND was
allowed to stabilize for at least 20 min before addition of
the following treatments: 1) Tyrode’s solution (control,
n = 6); 2) lyophilized V. flavicans extract (0.2, 0.5, 1,
and 2 mg/mL, n = 6); 3) 40 μg/mL Bjssu venom (n = 6);
4) pre-incubation for 30 min of 40 μg/mL Bjssu venom
and 1 mg/mLV. flavicans extract (n = 6), and 40 μg/mL
Bjssu venom pretreated preparation (10 min) followedby 1 mg/mLV. flavicans extract (n = 6). The venom con-
centration was based on a dose previously described in an
irreversible in vitro neuromuscular blockade assay [27].Antimicrobial activity
Bacterial strains and culture conditions
The following bacterial strains were purchased from Ameri-
can Type Culture Collection (ATCC): Escherichia coli ATCC
25922, E. coli ATCC 10536, Enterococcus faecalis ATCC
29212, Pseudomonas aeruginosa ATCC 25619, P. aeruginosa
ATCC 27853, Staphylococcus aureus ATCC 6538, S. aureus
ATCC 14458, S. aureus ATCC 29213, methicillin-resistant S.
aureus (MRSA) ATCC 33591, and methicillin/oxacillin
resistant S. aureus (MRSA/ORSA) ATCC 43300. The cul-
tures were stored at −80°C in Tryptic soy broth (TSB; Difco
Laboratories, Detroit, MI, USA) containing 40% (v/v) gly-
cerol and were routinely cultured in Tryptic soy agar (TSA;
Difco Laboratories) under aerobic conditions at 37°C.Determination of minimum inhibitory (MIC) and bactericidal
(MBC) concentrations
MIC and MBC values were determined by using the broth
microdilution method according to the guidelines from
the Clinical and Laboratory Standards Institute (CLSI)
protocol M07-A9. Briefly, four to five colonies were har-
vested from pure cultures growing on TSA and were used
to prepare a bacterial inoculum. Colonies were transferred
into tubes containing 5 mL of TSB and cultured at 37°C
until reaching turbidity equivalent to a 0.5 McFarland
standard (approximately 1.5 × 108 CFU/mL).
V. flavicans stock solutions in 50% ethanol (Merck,
Darmstadt, Germany) were diluted (2-fold serial dilu-
tions) in 100 μL Mueller Hinton Broth (MHB, Difco La-
boratories) in 96-well polystyrene microtiter plates at
concentrations ranging from 0.004 mg/mL to 10 mg/
mL.
The bacterial inoculum (100 μL) was then added into
each well, allowing a final concentration of 5 × 105 CFU/
mL. Plates were incubated under aerobic conditions at
37°C for 18 h and visually inspected for turbidity after
incubation. MIC was recorded as the lowest extract con-
centration that caused no turbidity. Solvent controls
were assayed with the treatments to verify their possible
antibacterial activity. Results were also compared with
vancomycin, gentamicin (positive controls), and ethanol
(negative control).
For MBC determination, 10 μL from each well with no
visible growth were plated on TSA and incubated at 37°C
for 24 h. MBC was considered as the lowest extract
concentration that completely inhibited (100%) the bac-
terial growth. Both MIC and MBC values (mg/mL)
were averaged from two different experiments per-
formed in replicate.
Tribuiani et al. BMC Complementary and Alternative Medicine 2014, 14:48 Page 4 of 9
http://www.biomedcentral.com/1472-6882/14/48Statistical analysis
Results are shown as the mean ± SEM. Number of ex-
periments (n) is indicated in the legend of the figure.
Student’s t-test was used to compare all data and the sig-
nificance level was set at 5%.
Results and discussion
One of the criteria for selecting plants for pharmaco-
logical studies is their traditional use in folk medicine
(ethnopharmacology). Selection is also based on chemical
composition, especially considering certain compounds
with well-known pharmacological activity [28,29]. In
the present study both criteria were considered, since V.
flavicans is traditionally used as an anti-inflammatory and
antirheumatic. In addition, its chemical composition has
been studied. Velloziaceae mainly contain flavonoids (phen-
olic compounds), diterpenes, and triterpenoids as the main
secondary metabolites. Terpenoid is a term used to indicate
that the substances have a common biosynthetic origin, the
isoprene molecule. Flavonols are related to natural resist-
ance factors and have some biological effects including anti-
microbial and cardiovascular activities [30]. Terpenoids
have other functions including growth-regulating proper-
ties, communication, and defense against insects [22].
After collection, botanical identification, stabilization,
grinding, and extraction, the plant extract was qualita-
tively analyzed by TLC [31] to obtain a chromatographic
fingerprint. TLC provides evidence of the plant’sFigure 1 Thin Layer Chromatography performed by using ethyl aceta
Developer: NP/PEG. Phytochemical standards (inside circles): 1 – mixture of
acid); 2 – V. flavicans extract; 3 – chlorogenic acid (Rf = 0.60); 4 – rutin (Rf =
of 0.99, 0.89, 0.80, 0.74, 0.70, 0.66, 0.60, 0.49, 0.23 and 0.13; 7 – caffeic acid (
flavonoids (yellow/orange fluorescence) and phenolics constituents (blue fl
Rf = retention factor.chemical composition. Figure 1 shows the TLC profile of
V. flavicans hydroalcoholic extract. Spots 2 and 6 indi-
cate phenolic compounds (observe the highlighted area,
Rf values were 0.99, 0.89, 0.80, 0.74, 0.70, 0.66, 0.60, 0.49,
0.23, and 0.13) including flavonols (yellow to orange fluor-
escence) and phenolic acids (blue fluorescence). A mixture
of commercial phytochemicals (chlorogenic acid + rutin +
quercetin + caffeic acid) is visualized in spot 1, chlorogenic
acid in 3, rutin in 4, quercetin in 5, and caffeic acid in 7.
Among the many compounds, note the presence of
chlorogenic acid (Rf 0.60) and quercetin (Rf 0.99) in V.
flavicans extract, representing phenolic acids and flavo-
nols, respectively. All of these phytochemicals were pre-
viously reported in Velloziaceae [10-17].
Chlorogenic and caffeic acids may act as antidotes
against snake venoms by binding to proteins through
hydrophobic interactions and hydrogen bonds [32]. Quer-
cetin is as a potent inhibitor of lipoxygenase, which ex-
plains its anti-inflammatory properties. Quercetin has a
phenolic hydroxyl group on carbon 5, a pyronic carbonyl
in close proximity, and coplanarity [33].
Even using other solvent systems, terpenoids were
not found when compared with their representative β-
sitosterol, the most abundant of the phytosteroids. Thus,
the TLC profile, acting as a plant quality control, allowed
the characterization of V. flavicans extract and comparison
with literature data. However, the pharmacological activity
is mainly attributed to flavonols.te:formic acid:acetic acid:water (100:11:11:24) as solvents.
commercial phytochemicals (chlorogenic acid, rutin, quercetin caffeic
0.48); 5 – quercetin (Rf = 0.99); 6 - V. flavicans extract, showing Rf values
Rf = dragged spot). V. flavicans extract spots are suggestive of several
uorescence), including quercetin and chlorogenic acid, respectively.
Figure 2 Mouse phrenic nerve-diaphragm preparations (indirect stimuli). Concentration-response curve of V. flavicans extract. Each
point represents mean ± SEM. * = statistically significant differences (p < 0.05) in comparison with Tyrode control.
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ability of plants and their chemical components to
neutralize snake venoms, and their anti-inflammatory
and antihepatotoxic properties. In the present study, B.
jararacussu venom was chosen to test if a plant with
anti-inflammatory properties also has antiophidian po-
tential, because B. jararacussu venom causes inflamma-
tion at the bite site [34] and causes an irreversible
neuromuscular blockade in vitro [7,35,36].
The clinical effects of B. jararacussu venom are well de-
scribed by Milani-Júnior et al. [37] and are similar to those
of other Bothrops species. Although the mechanism ofFigure 3 Isolated mouse phrenic nerve-diaphragm preparations (indi
significant differences (p < 0.05) in comparison with the venom.cytokine production induced by Bothrops venoms is not
completely understood [38], the compounds leading to in-
flammation are well established. Therefore, since the
anti-inflammatory properties are already attributed to
V. flavicans [8], we decided to test the ability of this
plant extract in neutralize the envenomation caused by
B. jararacussu venom in a well-controlled and previ-
ously validated experimental design.
The World Health Organization has included snake-
bite envenoming as a neglected disease [39]. Few efforts
have been carried out to change this, even considering
the existing serum therapy. As observed in the presentrect stimuli). Each point represents mean ± SEM. * = statistically
Figure 4 Representative recordings of the responses to: A, B. jararacussu venom (40 μg/mL) showing its characteristic irreversible
neuromuscular blockade (even after washing of preparation); B, pre-incubation of 40 μg/mL venom and 1 mg/mL extract during
30 min before addition into the bath; C, Extract addition (1 mg/mL, at 10 min, black arrow) in venom-pretreated preparation (40 μg/mL).
Blue arrows: start of experiment (zero time). Black arrow: extract addition. W =washing. Vertical bar = tension.
Table 1 Minimum inhibitory (MIC) and bactericidal (MBC)
concentrations (in mg/mL) for V. flavicans extract against
E. coli, E. faecalis, P. aeruginosa and S. aureus strains
Bacterial strains V. flavicans Vancomycin Gentamicin
MIC and MBC (mg/mL)
E. coli ATTC 25922 NF NF 0.0008
E. coli ATTC 10536 NF NF 0.0004
E. faecalis ATTC 29212 NF 0.0015 0.0125
P. aeruginosa ATTC 25619 2.5 NF 0.0002
P. aeruginosa ATTC 27853 2.5 NF 0.0004
S. aureus ATTC 6538 2.5 0.0008 0.0008
S. aureus ATTC 14458 2.5 0.0008 0.0004
S. aureus ATTC 29213 2.5 0.0008 0.0004
S. aureus ATTC 33591 2.5 0.0008 0.0015
S. aureus ATTC 43300 5.0 0.0008 NF
NF - no MIC or MBC were found considering the concentrations tested.
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native or a complementary therapy to serum treatment.
Figure 2 shows the dose-response curve (in mg/mL) of
V. flavicans hydroalcoholic extract. Concentrations of
0.2 mg/mL (p < 0.05); 0.5 mg/mL (p < 0.05) and 2 mg/mL
(p < 0.05), but not 1 mg/mL (p > 0.05), showed signifi-
cantly less twitch tension than Tyrode’s control solution,
indicating that these concentrations were able to interfere
with the normal contraction of PND. A better result
was obtained with 1 mg/mLV. flavicans extract, since
this concentration did not change the basal response of
neuromuscular preparation. Curiously, the low con-
centrations (0.2 and 0.5 mg/mL) caused a decrease in
the baseline (Tyrode’s solution). This result suggests a
parallel regulation on skeletal muscle excitability by an
unclear mechanism, since other endogenous signaling
pathways are capable to compensate the cholinergic con-
trol of movement. Glutamate, for example, was recently
suggested as a co-transmitter of acetylcholine in motoneu-
rons of mammalian neuromuscular junction [40,41].
Figure 3 shows the pharmacological profile of preincu-
bated (30 min) venom (40 μg/mL) plus V. flavicans extract
(1 mg/mL) compared with the venom alone and Tyrode’s
solution. The extract was able to completely abolish the
decreased twitch tension caused by B. jararacussu venom
at all times. At the end of experiment (120 min), the prep-
aration with V. flavicans extract was 97% (±10%) respon-
sive, indicating extract efficacy.
Effectiveness of mixing a plant extract or an isolated
phytochemical with a venom to abolish the venom toxiceffects is not guaranteed. Success depends on the
venom and plant constituents. The main constituents
of V. flavicans very closely reproduce the results obtained
with the hydroalcoholic extract of Casearia sylvestris Sw.
[42] or Casearia gossypiosperma Briq. [43], which are rich
in flavonoids and polyphenols. However, the results were
not similar with those observed for Dipteryx alata, which
is rich in triterpenoids [26,44]; Mikania laevigata, which
is rich in coumarin [45]; Plathymenia reticulata Benth.,
which is rich in tannins [46]; or Camellia sinensis, which
is rich in catechins [36]. Nevertheless, except for tannins
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[45], most of the mechanisms of action of other phyto-
chemicals remain unclear.
Figure 4 shows the representative myographic register
of B. jararacussu venom (A, 40 μg/mL) exhibiting the
characteristic irreversible muscle paralysis. When venom
(40 μg/mL) + V. flavicans extract (1 mg/mL) are prein-
cubated together for 30 min before addition into the
bath, the toxic effect of the venom was not expressed
(B). This result shows the total protection given by the
plant extract against the venom, probably by a mechan-
ism that excludes protein precipitation, as seen in tannins
and tannic acid [45]. Even in preparations pretreated with
B. jararacussu (40 μg/mL) for 10 min, which showed con-
tracture and 40% of visible paralysis, the addition of
1 mg/mLV. flavicans extract into the bath was able to
delay the paralysis progression, in a non-preincubated
model (C). The mechanism of the in vitro, but not the
in vivo, neuromuscular paralysis caused by B. jarara-
cussu venom was recently demonstrated [36]. There is
a direct relationship between the cell damage level and
the percentage of twitch tension response [43].
The antimicrobial activities (MIC and MBC) of V. flavi-
cans extract against E. coli, E. faecalis, P. aeruginosa, and S.
aureus strains values are shown in Table 1. All susceptible
bacterial species were inhibited or killed by vancomycin
and/or gentamicin, in accordance to the recommendations
of CLSI. Ethanol (extract solvent) did not interfere with
bacterial growth in the concentrations tested.
To assess the antimicrobial activity of a plant extract,
strict endpoint criteria for MIC, IC50 and/or IC90 must
be considered. Generally an extract can be considered
effective if it shows IC50 lower than 100 μg/mL [47]. The
MIC values found in the present study were up to 50
times higher than the concentration considered as the
maximum concentration acceptable for IC50. Therefore,
V. flavicans extract does not possess relevant antibacter-
ial activity, considering the high values of MIC and
MBC for P. aeruginosa and S. aureus strains (2.5–
5.0 mg/ml) and the absence of inhibition of E. coli and
E. faecalis strains.
Some specific plants extracts and metabolites can be
effective against microorganisms and snake envenom-
ation. Andrographis paniculata demonstrated activity
against different pathogenic microorganisms [48] and it
has anti-venom activity against Naja naja venom [49].
Vitis vinifera can effectively inhibit toxic effects, such as
edema, hemorrhage, myonecrosis, and coagulation of
human plasma induced by Echis carinatus venom [50].
V. vinifera can also inhibit the growth of S. aureus, E.
coli, and Bacillus cereus [51]. A plant extract showing
both anti-venom and antimicrobial activities would be
very useful since it could be used to prevent or to treat
local/systemic infection caused by snakebite [2]. AlthoughV. flavicans extract did not show good antimicrobial activ-
ity and a more appropriate experimental inflammation
model was not used [34], the extract showed potential for
treating Bothrops snake envenomation.
Conclusions
In conclusion, the V. flavicans hydroalcoholic extract
showed promising results against the in vitro neuromus-
cular blockade-induced by B. jararacussu venom at the
nerve-muscle apparatus. The extract reduced the charac-
teristic cell damage induced by the venom and avoided
cell damage progression.
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